Attached files
file | filename |
---|---|
10-K/A - China Botanic Pharmaceutical | v167850_10ka.htm |
EX-32.1 - China Botanic Pharmaceutical | v167850_ex32-1.htm |
EX-23.1 - China Botanic Pharmaceutical | v167850_ex23-1.htm |
EX-31.2 - China Botanic Pharmaceutical | v167850_ex31-2.htm |
EX-31.1 - China Botanic Pharmaceutical | v167850_ex31-1.htm |
EXHIBIT
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Renhuang Pharmaceuticals, Inc. (the
“Company”) on Form 10-K/A for the period ending October 31, 2008, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Zuoliang Wang, Interim Chief Financial Officer of the Company, hereby
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, based upon a
review of the Report:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operation of the Company.
/s/ Zuoliang
Wang
|
Zuoliang
Wang
|
Interim
Chief Financial Officer
(Principle
Financial Officer)
|
Dated:
December 8, 2009